首页 > 最新文献

Chinese Medical Sciences Journal最新文献

英文 中文
Vascular Calcification: Where is the Cure? 血管钙化:治疗方法在哪里?
Q2 Medicine Pub Date : 2024-09-04 DOI: 10.24920/004367
Wen-Wen Liu, Mei-Lin Liu

With the progress of aging, the incidence of vascular calcification (VC) gradually increases, which is correlated with cardiovascular events and all-cause death, aggravating global clinical burden. Over the past several decades, accumulating approaches targeting the underlying pathogenesis of VC have provided some possibilities for the treatment of VC. Unfortunately, none of the current interventions have achieved clinical effectiveness on reversing or curing VC. The purpose of this review is to make a summary of novel perspectives on the interventions of VC and provide reference for clinical decision-making.

随着年龄的增长,血管钙化(VC)的发病率逐渐升高,它与心血管事件和全因死亡相关,加重了全球的临床负担。过去几十年来,针对血管钙化潜在发病机制的方法不断积累,为血管钙化的治疗提供了一些可能性。遗憾的是,目前还没有一种干预措施能在临床上有效逆转或治愈 VC。本综述的目的是总结有关VC干预措施的新观点,为临床决策提供参考。
{"title":"Vascular Calcification: Where is the Cure?","authors":"Wen-Wen Liu, Mei-Lin Liu","doi":"10.24920/004367","DOIUrl":"https://doi.org/10.24920/004367","url":null,"abstract":"<p><p>With the progress of aging, the incidence of vascular calcification (VC) gradually increases, which is correlated with cardiovascular events and all-cause death, aggravating global clinical burden. Over the past several decades, accumulating approaches targeting the underlying pathogenesis of VC have provided some possibilities for the treatment of VC. Unfortunately, none of the current interventions have achieved clinical effectiveness on reversing or curing VC. The purpose of this review is to make a summary of novel perspectives on the interventions of VC and provide reference for clinical decision-making.</p>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alignment Techniques in Total Knee Arthroplasty:Where do We Stand Today? 全膝关节置换术中的对位技术:我们的现状如何?
Q2 Medicine Pub Date : 2024-08-05 DOI: 10.24920/004372
Dhungana Hemanta, Jangid Subhash, Goyal Meghal

Achieving optimal alignment in total knee arthroplasty (TKA) is a critical factor in ensuring optimal outcomes and long-term implant survival. Traditionally, mechanical alignment has been favored to achieve neutral post-operative joint alignment. However, contemporary approaches, such as kinematic alignments and hybrid techniques including adjusted mechanical, restricted kinematic, inverse kinematic, and functional alignments, are gaining attention for their ability to restore native joint kinematics and anatomical alignment, potentially leading to enhanced functional outcomes and greater patient satisfaction. The ongoing debate on optimal alignment strategies considers the following factors: long-term implant durability, functional improvement, and resolution of individual anatomical variations. Furthermore, advancements of computer-navigated and robotic-assisted surgery has augmented the precision in implant positioning and objective measurements of soft tissue balance. Despite ongoing debates on balancing implant longevity and functional outcomes, there is an increasing advocacy for personalized alignment strategies that are tailored to individual anatomical variations. This review evaluates the spectrum of various alignment techniques in TKA, including mechanical alignment, patient-specific kinematic approaches, and emerging hybrid methods. Each technique is scrutinized based on its fundamental principles, procedural techniques, inherent advantages, and potential limitations, while identifying significant clinical gaps that underscore the need for further investigation.

在全膝关节置换术(TKA)中实现最佳对位是确保最佳治疗效果和植入物长期存活的关键因素。传统上,人们倾向于采用机械式对位来实现术后关节的中性对位。然而,运动学对位和混合技术(包括调整机械对位、限制性运动学对位、反向运动学对位和功能性对位)等现代方法因其能够恢复原始关节运动学和解剖学对位而日益受到关注,并有可能提高功能性治疗效果和患者满意度。目前关于最佳对位策略的争论主要考虑以下因素:植入物的长期耐久性、功能改善以及个体解剖变异的解决。此外,计算机导航和机器人辅助手术的发展也提高了种植体定位的精确度和软组织平衡的客观测量。尽管人们一直在争论如何平衡种植体的寿命和功能效果,但越来越多的人主张根据个体解剖变异制定个性化的对位策略。本综述评估了 TKA 中的各种对位技术,包括机械对位、患者特异性运动学方法和新兴的混合方法。每种技术都根据其基本原理、程序技术、固有优势和潜在局限性进行了仔细研究,同时找出了临床上的重大差距,强调了进一步研究的必要性。
{"title":"Alignment Techniques in Total Knee Arthroplasty:Where do We Stand Today?","authors":"Dhungana Hemanta, Jangid Subhash, Goyal Meghal","doi":"10.24920/004372","DOIUrl":"https://doi.org/10.24920/004372","url":null,"abstract":"<p><p>Achieving optimal alignment in total knee arthroplasty (TKA) is a critical factor in ensuring optimal outcomes and long-term implant survival. Traditionally, mechanical alignment has been favored to achieve neutral post-operative joint alignment. However, contemporary approaches, such as kinematic alignments and hybrid techniques including adjusted mechanical, restricted kinematic, inverse kinematic, and functional alignments, are gaining attention for their ability to restore native joint kinematics and anatomical alignment, potentially leading to enhanced functional outcomes and greater patient satisfaction. The ongoing debate on optimal alignment strategies considers the following factors: long-term implant durability, functional improvement, and resolution of individual anatomical variations. Furthermore, advancements of computer-navigated and robotic-assisted surgery has augmented the precision in implant positioning and objective measurements of soft tissue balance. Despite ongoing debates on balancing implant longevity and functional outcomes, there is an increasing advocacy for personalized alignment strategies that are tailored to individual anatomical variations. This review evaluates the spectrum of various alignment techniques in TKA, including mechanical alignment, patient-specific kinematic approaches, and emerging hybrid methods. Each technique is scrutinized based on its fundamental principles, procedural techniques, inherent advantages, and potential limitations, while identifying significant clinical gaps that underscore the need for further investigation.</p>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141890279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linggui Zhugan Decoction Improves High Glucose-Induced Autophagy in Podocytes. 灵桂术甘煎剂能改善高血糖诱导的荚膜细胞自噬现象
Q2 Medicine Pub Date : 2024-07-02 DOI: 10.24920/004330
Yuan-Yuan Wang, Jian Qin, Ru-Lan Zhang, Min-Ji Yu, Ming-Hua Jin

Objective To explore the influence of Linggui Zhugan Decoction (LGZGD) on high glucose induced podocyte autophagy Methods LGZGD containing serum were prepared by intragastric administation of 4.2 g·kg-1 (low dose), 8.4 g·kg-1 (medium dose), and 12.6 g·kg-1 (high dose) LGZGD into SD rats respectively. MPC5 and AB8/13 cells were treated with 60 mmol/L glucose to establish diabetic nephropathy podocyte model in vitro. Podocytes, MPC5 and AB8.13, were divided into control group, high glucose group, low dose LGZGD group, medium dose LGZGD group, and high dose LGZGD group, respectively. For the three LGZGD groups, before LGZGD intervention, podocytes were treated with 60 mmol/L glucose for 3 days. After treated with LGZGD containing serum, cells were collected to analyze cell migration using Transwell assay, proliferation using CCK8, apoptosis and cell cycle using flow cytometry,, autophagosome formation using transmission electron microscopy, and expression levels of Beclin-1, Atg5, LC3II/I, and P62 proteins using western blot.Results Compared with the control group, the proliferation and migration of MPC5 and AB8.13 cells in high glucose group showed slightly decreased, whereas these parameters restored after intervention with low and medium concentrations of LGZGD, with the medium dose LGZGD having the best effect. Flow cytometry analysis showed that the medium dose LGZGD group had a lower apoptosis rate (P < 0.05) and higher survival rate (P > 0.05) compared to the high dose group. High glucose arrested podocytes in G1 phase, whereas LGZGD shifted podocytes from being predominant in G1 phase to increasing into G2. High dose LGZGD significanly reduced increased autophagosome formation due to high glucose in both podocytes (P < 0.05). Western blot analysis showed that Beclin-1, Atg5, LC3Ⅱ/Ⅰ, and P62 expressions were increased in MPC5 cells treated with high glucose, and reversed after adminstration of low and medium doses of LGZGD (P < 0.05). Conclusion LGZGD reduced apoptosis and enhanced autophagy in high glucose treated podocytes via regulating Beclin-1/LC3II/I/Atg5 expression.

方法 分别给 SD 大鼠胃内注射 4.2 g-kg-1(低剂量)、8.4 g-kg-1(中剂量)和 12.6 g-kg-1(高剂量)含血清的 LGZGD。用 60 mmol/L 葡萄糖处理 MPC5 和 AB8/13 细胞,在体外建立糖尿病肾病荚膜细胞模型。荚膜细胞、MPC5和AB8.13分别被分为对照组、高葡萄糖组、低剂量LGZGD组、中剂量LGZGD组和高剂量LGZGD组。三个 LGZGD 组在使用 LGZGD 之前,先用 60 mmol/L 葡萄糖处理荚膜细胞 3 天。用含血清的 LGZGD 处理后,收集细胞,用 Transwell 试验分析细胞迁移,用 CCK8 分析细胞增殖,用流式细胞术分析细胞凋亡和细胞周期,用透射电子显微镜分析自噬体的形成,用 Western 印迹分析 Beclin-1、Atg5、LC3II/I 和 P62 蛋白的表达水平。结果 与对照组相比,高糖组 MPC5 和 AB8.13 细胞的增殖和迁移能力略有下降,而使用中低浓度 LGZGD 干预后,这些指标均得到恢复,其中中剂量 LGZGD 的效果最好。流式细胞术分析表明,与高剂量组相比,中剂量 LGZGD 组的凋亡率较低(P < 0.05),存活率较高(P > 0.05)。高糖使荚膜细胞停滞在 G1 期,而 LGZGD 则使荚膜细胞从 G1 期占优势转变为进入 G2 期。高剂量 LGZGD 显著减少了两种荚膜细胞因高糖而增加的自噬体形成(P < 0.05)。Western印迹分析表明,高糖处理的MPC5细胞中Beclin-1、Atg5、LC3Ⅱ/Ⅰ和P62表达增加,而中低剂量的LGZGD可逆转这些表达(P < 0.05)。结论 LGZGD通过调节Beclin-1/LC3Ⅱ/I/Atg5的表达,减少了高糖处理的荚膜细胞的凋亡并增强了其自噬能力。
{"title":"Linggui Zhugan Decoction Improves High Glucose-Induced Autophagy in Podocytes.","authors":"Yuan-Yuan Wang, Jian Qin, Ru-Lan Zhang, Min-Ji Yu, Ming-Hua Jin","doi":"10.24920/004330","DOIUrl":"https://doi.org/10.24920/004330","url":null,"abstract":"<p><p>Objective To explore the influence of Linggui Zhugan Decoction (LGZGD) on high glucose induced podocyte autophagy Methods LGZGD containing serum were prepared by intragastric administation of 4.2 g·kg<sup>-1 (</sup>low dose<sup>)</sup>, 8.4 g·kg<sup>-1</sup> (medium dose), and 12.6 g·kg<sup>-1</sup> (high dose) LGZGD into SD rats respectively. MPC5 and AB8/13 cells were treated with 60 mmol/L glucose to establish diabetic nephropathy podocyte model in vitro. Podocytes, MPC5 and AB8.13, were divided into control group, high glucose group, low dose LGZGD group, medium dose LGZGD group, and high dose LGZGD group, respectively. For the three LGZGD groups, before LGZGD intervention, podocytes were treated with 60 mmol/L glucose for 3 days. After treated with LGZGD containing serum, cells were collected to analyze cell migration using Transwell assay, proliferation using CCK8, apoptosis and cell cycle using flow cytometry,, autophagosome formation using transmission electron microscopy, and expression levels of Beclin-1, Atg5, LC3II/I, and P62 proteins using western blot.Results Compared with the control group, the proliferation and migration of MPC5 and AB8.13 cells in high glucose group showed slightly decreased, whereas these parameters restored after intervention with low and medium concentrations of LGZGD, with the medium dose LGZGD having the best effect. Flow cytometry analysis showed that the medium dose LGZGD group had a lower apoptosis rate (P < 0.05) and higher survival rate (P > 0.05) compared to the high dose group. High glucose arrested podocytes in G1 phase, whereas LGZGD shifted podocytes from being predominant in G1 phase to increasing into G2. High dose LGZGD significanly reduced increased autophagosome formation due to high glucose in both podocytes (P < 0.05). Western blot analysis showed that Beclin-1, Atg5, LC3Ⅱ/Ⅰ, and P62 expressions were increased in MPC5 cells treated with high glucose, and reversed after adminstration of low and medium doses of LGZGD (P < 0.05). Conclusion LGZGD reduced apoptosis and enhanced autophagy in high glucose treated podocytes via regulating Beclin-1/LC3II/I/Atg5 expression.</p>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vertebral Artery Stenting for Acute Multiple Cerebral Infarctions Caused by Vertebral Artery Dissection After Massage: A Case Report 椎动脉支架植入术治疗按摩后椎动脉离断引起的急性多发性脑梗塞:病例报告。
Q2 Medicine Pub Date : 2024-06-01 DOI: 10.24920/004336

Vertebral artery dissection is a rare pathology that can cause ischemic stroke in young people. Cervical massage, especially improper pulling manipulation, is a cause of vertebral artery dissection. We present a case of 32-year-old woman who developed acute multiple posterior circulation ischemic cerebral infarctions as a result of left vertebral artery V4 segment dissection after receiving neck massage. She underwent emergency vertebral artery stent implantation at the site of the dissection. Symptoms were relieved the day after treatment. The patient recovered without adverse complications or endovascular restenosis in the following year.

椎动脉夹层是一种导致年轻人缺血性中风的罕见病变。颈椎按摩,尤其是不当的牵拉手法,是导致椎动脉夹层的原因之一。我们报告了一例 32 岁女性患者,她在接受颈部按摩后因左侧椎动脉 V4 节段夹层导致急性多发性后循环缺血性脑梗死。她在夹层部位接受了急诊椎动脉支架植入术。治疗后第二天症状就得到了缓解。次年,患者康复,未出现不良并发症或血管内再狭窄。
{"title":"Vertebral Artery Stenting for Acute Multiple Cerebral Infarctions Caused by Vertebral Artery Dissection After Massage: A Case Report","authors":"","doi":"10.24920/004336","DOIUrl":"10.24920/004336","url":null,"abstract":"<div><p>Vertebral artery dissection is a rare pathology that can cause ischemic stroke in young people. Cervical massage, especially improper pulling manipulation, is a cause of vertebral artery dissection. We present a case of 32-year-old woman who developed acute multiple posterior circulation ischemic cerebral infarctions as a result of left vertebral artery V4 segment dissection after receiving neck massage. She underwent emergency vertebral artery stent implantation at the site of the dissection. Symptoms were relieved the day after treatment. The patient recovered without adverse complications or endovascular restenosis in the following year.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141076846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Brief Overview of the Development and Significance of Modern Scientific Medicine in China: Take Chinese Academy of Medical Science and Peking Union Medical College as an Example 简述中国现代科学医学的发展及其意义:以中国医学科学院和中国协和医科大学为例。
Q2 Medicine Pub Date : 2024-06-01 DOI: 10.24920/004316

Since the early 20th century, China has gradually established a clinical, educational, and research system centered around modern scientific medicine, which has now become the dominant force in China's medical and health system and services, with the construction and development of the Chinese Academy of Medical Sciences and Peking Union Medical College as the most prominent symbol. The scientific medicine in the new era requires close cooperation across multiple disciplines and fields to build a high-quality and efficient medical and health service system. It also involves combining the excellent traditional Chinese culture with Western medicine to explore a unique path of modern scientific medicine with Chinese characteristics.

自 20 世纪初以来,中国逐步建立起了以现代科学医学为核心的临床、教育和科研体系,目前已成为中国医疗卫生体系和服务的主导力量,中国医学科学院和中国协和医科大学的建设和发展就是最突出的标志。新时代的科学医疗需要多学科、多领域的紧密合作,构建优质高效的医疗卫生服务体系。同时,还需要将中华优秀传统文化与西方现代医学相结合,探索出一条独具中国特色的现代科学医学之路。
{"title":"A Brief Overview of the Development and Significance of Modern Scientific Medicine in China: Take Chinese Academy of Medical Science and Peking Union Medical College as an Example","authors":"","doi":"10.24920/004316","DOIUrl":"10.24920/004316","url":null,"abstract":"<div><p>Since the early 20th century, China has gradually established a clinical, educational, and research system centered around modern scientific medicine, which has now become the dominant force in China's medical and health system and services, with the construction and development of the Chinese Academy of Medical Sciences and Peking Union Medical College as the most prominent symbol. The scientific medicine in the new era requires close cooperation across multiple disciplines and fields to build a high-quality and efficient medical and health service system. It also involves combining the excellent traditional Chinese culture with Western medicine to explore a unique path of modern scientific medicine with Chinese characteristics.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The “4+4” Medical Doctor (MD) Pilot Program at PUMC: Implementation, Performance, and Prospects PUMC 的 "4+4 "医学教育试点项目:实施、绩效和前景。
Q2 Medicine Pub Date : 2024-06-01 DOI: 10.24920/004378

Peking Union Medical College (PUMC) launched the “4+4” Medical Doctor (MD) pilot program in 2018, admitting students with non-medical backgrounds from top universities, aligning with national medical talent training policies to foster diverse and eager learners in medicine. On the occasion of the graduation of the first class of the “4+4” MD pilot class at PUMC in 2023, we reviewed the teaching reform in the pilot program and carried out a systematic survey and interviews with students, faculties, and management staff of the pilot class. This article reports on the measures taken by the pilot class at PUMC in enrollment and curriculum setting, and demonstrates the achievements of the pilot class in terms of student academic background structure, knowledge acquisition and skill learning, scientific research ability, and course evaluation. The results indicated that the pilot class had met the national demand for the “Medicine + X” talent training model. More specifically, with a diverse academic backgrounds, the pilot class graduates had academic levels comparable to the eight-year medical education graduates, and their scientific research abilities were satisfactory. The pilot program at PUMC will optimize the curriculum setting, strengthen the construction of faculty, learning resources, and teaching facilities, and reform the academic evaluation methods, thus deepening the reform of medical education and improving the “4+4” MD program as a novel medical education model.

北京协和医学院于2018年启动 "4+4 "临床医学实验班,招收来自一流大学的非医学专业背景学生,与国家医学人才培养政策接轨,培养多元化、好学上进的医学人才。在2023年北京大学医学部 "4+4 "临床医学实验班首届学生毕业之际,我们对实验班的教学改革进行了回顾,并对实验班的学生、教师和管理人员进行了系统的调查和访谈。本文报告了浦医大试点班在招生、课程设置等方面采取的措施,展示了试点班在学生学科背景结构、知识掌握与技能学习、科学研究能力、课程评价等方面取得的成绩。结果表明,试点班满足了国家对 "医学+x "人才培养模式的需求。具体而言,试点班毕业生学历背景多元,学术水平与八年制医学教育毕业生相当,科研能力令人满意。北京大学医学部试点班将优化课程设置,加强师资队伍、学习资源和教学设施建设,改革学业评价方式,从而深化医学教育改革,完善 "4+4 "医学博士项目这一新型医学教育模式。
{"title":"The “4+4” Medical Doctor (MD) Pilot Program at PUMC: Implementation, Performance, and Prospects","authors":"","doi":"10.24920/004378","DOIUrl":"10.24920/004378","url":null,"abstract":"<div><p>Peking Union Medical College (PUMC) launched the “4+4” Medical Doctor (MD) pilot program in 2018, admitting students with non-medical backgrounds from top universities, aligning with national medical talent training policies to foster diverse and eager learners in medicine. On the occasion of the graduation of the first class of the “4+4” MD pilot class at PUMC in 2023, we reviewed the teaching reform in the pilot program and carried out a systematic survey and interviews with students, faculties, and management staff of the pilot class. This article reports on the measures taken by the pilot class at PUMC in enrollment and curriculum setting, and demonstrates the achievements of the pilot class in terms of student academic background structure, knowledge acquisition and skill learning, scientific research ability, and course evaluation. The results indicated that the pilot class had met the national demand for the “Medicine + X” talent training model. More specifically, with a diverse academic backgrounds, the pilot class graduates had academic levels comparable to the eight-year medical education graduates, and their scientific research abilities were satisfactory. The pilot program at PUMC will optimize the curriculum setting, strengthen the construction of faculty, learning resources, and teaching facilities, and reform the academic evaluation methods, thus deepening the reform of medical education and improving the “4+4” MD program as a novel medical education model.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141447207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Accuracy of Computerized Bowel Sound Analysis with Non-Invasive Devices for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis 计算机肠鸣音分析与非侵入性设备对肠易激综合征的诊断准确性:系统回顾与元分析》。
Q2 Medicine Pub Date : 2024-06-01 DOI: 10.24920/004307

Objective

To assess the diagnostic accuracy of bowel sound analysis for irritable bowel syndrome (IBS) with a systematic review and meta-analysis.

Methods

We searched MEDLINE, Embase, the Cochrane Library, Web of Science, and IEEE Xplore databases until September 2023. Cross-sectional and case-control studies on diagnostic accuracy of bowel sound analysis for IBS were identified. We estimated the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio with a 95% confidence interval (CI), and plotted a summary receiver operating characteristic curve and evaluated the area under the curve.

Results

Four studies were included. The pooled diagnostic sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 0.94 (95% CI, 0.87–0.97), 0.89 (95% CI, 0.81–0.94), 8.43 (95% CI, 4.81–14.78), 0.07 (95% CI, 0.03–0.15), and 118.86 (95% CI, 44.18–319.75), respectively, with an area under the curve of 0.97 (95% CI, 0.95–0.98).

Conclusions

Computerized bowel sound analysis is a promising tool for IBS. However, limited high-quality data make the results' validity and applicability questionable. There is a need for more diagnostic test accuracy studies and better wearable devices for monitoring and analysis of IBS.

目的 通过系统综述和荟萃分析评估肠易激综合征(IBS)肠鸣音分析的诊断准确性。方法 我们检索了 MEDLINE、EMBASE、Cochrane Library、Web of Science 和 IEEE Xplore 数据库,直至 2023 年 9 月。确定了肠鸣音分析对肠易激综合征诊断准确性的横断面研究和病例对照研究。我们估算了汇总的灵敏度、特异性、阳性似然比、阴性似然比和诊断几率比(含 95% 置信区间 (CI)),绘制了接收者操作特征曲线并评估了曲线下面积。结果 共纳入四项研究。汇总的诊断灵敏度、特异性、阳性似然比、阴性似然比和诊断几率比分别为 0.94(95% CI,0.87-0.97)、0.89(95% CI,0.81-0.94)、8.43(95% CI,4.81-14.78)、0.07(95% CI,0.03-0.15)和 118.86(95% CI,44.18-319.75),曲线下面积为 0.97(95% CI,0.95-0.98)。结论 计算机肠鸣音分析是一种治疗肠易激综合征的有效工具。然而,由于高质量数据有限,其结果的有效性和适用性值得怀疑。需要进行更多的诊断测试准确性研究和更好的可穿戴设备来进行监测和分析。
{"title":"Diagnostic Accuracy of Computerized Bowel Sound Analysis with Non-Invasive Devices for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis","authors":"","doi":"10.24920/004307","DOIUrl":"10.24920/004307","url":null,"abstract":"<div><h3>Objective</h3><p>To assess the diagnostic accuracy of bowel sound analysis for irritable bowel syndrome (IBS) with a systematic review and meta-analysis.</p></div><div><h3>Methods</h3><p>We searched MEDLINE, Embase, the Cochrane Library, Web of Science, and IEEE Xplore databases until September 2023. Cross-sectional and case-control studies on diagnostic accuracy of bowel sound analysis for IBS were identified. We estimated the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio with a 95% confidence interval (<em>CI</em>), and plotted a summary receiver operating characteristic curve and evaluated the area under the curve.</p></div><div><h3>Results</h3><p>Four studies were included. The pooled diagnostic sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 0.94 (95% <em>CI</em>, 0.87–0.97), 0.89 (95% <em>CI</em>, 0.81–0.94), 8.43 (95% <em>CI</em>, 4.81–14.78), 0.07 (95% <em>CI</em>, 0.03–0.15), and 118.86 (95% <em>CI</em>, 44.18–319.75), respectively, with an area under the curve of 0.97 (95% <em>CI</em>, 0.95–0.98).</p></div><div><h3>Conclusions</h3><p>Computerized bowel sound analysis is a promising tool for IBS. However, limited high-quality data make the results' validity and applicability questionable. There is a need for more diagnostic test accuracy studies and better wearable devices for monitoring and analysis of IBS.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140719043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Raw Corn Starch in Insulinoma-Related Hypoglycemia: A Promising Supportive Therapy 生玉米淀粉对胰岛素瘤导致的低血糖症的疗效:一种前景看好的辅助疗法
Q2 Medicine Pub Date : 2024-06-01 DOI: 10.24920/004329

Objective

To investigate the efficacy of raw corn starch (RCS) in clinical management of insulinoma-induced hypoglycemia.

Methods

We retrospectively collected clinical data of insulinoma patients who received RCS-supplemented diet preoperatively, and analyzed the therapeutic effects of the RCS intervention on blood glucose control, weight change, and its adverse events.

Results

The study population consisted of 24 cases of insulinoma patients, 7 males and 17 females, aged 46.08±14.15 years. Before RCS-supplemented diet, all patients had frequent hypoglycemic episodes (2.51±3.88 times/week), concurrent with neuroglycopenia (in 83.3% of patients) and autonomic manifestations (in 75.0% of patients), with the median fasting blood glucose (FBG) of 2.70 (interquartile range [IQR]: 2.50–2.90) mmol/L. The patients' weight increased by 0.38 (IQR: 0.05 – 0.65) kg per month, with 8 (33.3%) cases developing overweight and 7 (29.2%) cases developing obesity. All patients maintained the RCS-supplemented diet until they underwent tumor resection (23 cases) and transarterial chemoembolization for liver metastases (1 case). For 19 patients receiving RCS throughout the day, the median FBG within one week of nutritional management was 4.30 (IQR: 3.30–5.70) mmol/L, which was a significant increase compared to pre-nutritional level [2.25 (IQR: 1.60–2.90) mmol/L; P < 0.001]. Of them, 10 patients receiving RCS throughout the day for over four weeks had sustained improvement in FBG compared to pre-treatment [3.20 (IQR: 2.60–3.95) mmol/L vs. 2.15 (IQR: 1.83 – 2.33) mmol/L; P < 0.001). Five patients who received RCS only at night also had a significant increase in FBG within one week of nutritional management [3.50 (IQR: 2.50–3.65) mmol/L vs. 2.20 (IQR: 1.80–2.60) mmol/L; P < 0.001], but only one patient who continued to receive RCS for over four weeks did not have a significant improvement in FBG. No improvement in weight gain was observed upon RCS supplementation. Mild diarrhea (2 cases) and flatulence (1 case) occurred, and were relieved by reduction of RCS dose.

Conclusion

The RCS-supplemented diet is effective in controlling insulinoma-induced hypoglycemia.

目的 探讨生玉米淀粉(RCS)在胰岛素瘤所致低血糖临床治疗中的疗效。方法 回顾性收集术前接受RCS辅助饮食的胰岛素瘤患者的临床资料,分析RCS干预对血糖控制、体重变化及其不良反应的治疗效果。补充 RCS 饮食前,所有患者均频繁发生低血糖(2.51 ± 3.88 次/周),同时伴有神经性糖耐量减低症(83.3% 的患者)和自主神经表现(75.0% 的患者),空腹血糖(FBG)中位数为 2.70 [四分位数间距(IQR):2.50-2.90] mmol/L。患者体重每月增加 0.38(IQR:0.05-0.65)千克,其中 8 例(33.3%)发展为超重,7 例(29.2%)发展为肥胖。所有患者在接受肿瘤切除术(23 例)和经动脉化疗栓塞治疗肝转移瘤(1 例)之前,一直保持补充 RCS 的饮食习惯。19 名全天接受 RCS 的患者在营养管理一周内的 FBG 中位数为 4.30(IQR:3.30-5.70)mmol/L,与营养前水平 [2.25 (IQR:1.60-2.90)mmol/L;P = 0.000]相比显著增加。其中,10 名患者全天接受 RCS 超过四周,与治疗前相比,FBG 有持续改善 [3.20 (IQR: 2.60-3.95) mmol/L vs. 2.15 (IQR: 1.83-2.33) mmol/L;P = 0.000]。五名仅在夜间接受 RCS 的患者的 FBG 也在营养管理一周内显著增加 [3.50 (IQR: 2.50-3.65) mmol/L vs. 2.20 (IQR:1.80-2.60) mmol/L;P = 0.000],但只有一名持续接受 RCS 超过 4 周的患者的 FBG 没有显著改善。补充 RCS 后体重增加没有改善。出现轻度腹泻(2 例)和胀气(1 例),减少 RCS 剂量后症状缓解。
{"title":"Efficacy of Raw Corn Starch in Insulinoma-Related Hypoglycemia: A Promising Supportive Therapy","authors":"","doi":"10.24920/004329","DOIUrl":"10.24920/004329","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the efficacy of raw corn starch (RCS) in clinical management of insulinoma-induced hypoglycemia.</p></div><div><h3>Methods</h3><p>We retrospectively collected clinical data of insulinoma patients who received RCS-supplemented diet preoperatively, and analyzed the therapeutic effects of the RCS intervention on blood glucose control, weight change, and its adverse events.</p></div><div><h3>Results</h3><p>The study population consisted of 24 cases of insulinoma patients, 7 males and 17 females, aged 46.08±14.15 years. Before RCS-supplemented diet, all patients had frequent hypoglycemic episodes (2.51±3.88 times/week), concurrent with neuroglycopenia (in 83.3% of patients) and autonomic manifestations (in 75.0% of patients), with the median fasting blood glucose (FBG) of 2.70 (interquartile range [IQR]: 2.50–2.90) mmol/L. The patients' weight increased by 0.38 (IQR: 0.05 – 0.65) kg per month, with 8 (33.3%) cases developing overweight and 7 (29.2%) cases developing obesity. All patients maintained the RCS-supplemented diet until they underwent tumor resection (23 cases) and transarterial chemoembolization for liver metastases (1 case). For 19 patients receiving RCS throughout the day, the median FBG within one week of nutritional management was 4.30 (IQR: 3.30–5.70) mmol/L, which was a significant increase compared to pre-nutritional level [2.25 (IQR: 1.60–2.90) mmol/L; <em>P</em> &lt; 0.001]. Of them, 10 patients receiving RCS throughout the day for over four weeks had sustained improvement in FBG compared to pre-treatment [3.20 (IQR: 2.60–3.95) mmol/L <em>vs</em>. 2.15 (IQR: 1.83 – 2.33) mmol/L; <em>P</em> &lt; 0.001). Five patients who received RCS only at night also had a significant increase in FBG within one week of nutritional management [3.50 (IQR: 2.50–3.65) mmol/L <em>vs</em>. 2.20 (IQR: 1.80–2.60) mmol/L; <em>P</em> &lt; 0.001], but only one patient who continued to receive RCS for over four weeks did not have a significant improvement in FBG. No improvement in weight gain was observed upon RCS supplementation. Mild diarrhea (2 cases) and flatulence (1 case) occurred, and were relieved by reduction of RCS dose.</p></div><div><h3>Conclusion</h3><p>The RCS-supplemented diet is effective in controlling insulinoma-induced hypoglycemia.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140959759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a Decision Aid for Family Surrogate Decision Makers of Critically Ill Patients Requiring Renal Replacement Therapy in ICU: A User-Centered Design for Rapid Prototyping 为需要接受肾脏替代治疗的重症监护室危重病人的家庭代理决策者开发决策辅助工具:以用户为中心的快速原型设计。
Q2 Medicine Pub Date : 2024-06-01 DOI: 10.24920/004326

Objective

Renal replacement therapy (RRT) is increasingly adopted for critically ill patients diagnosed with acute kidney injury, but the optimal time for initiation remains unclear and prognosis is uncertain, leading to medical complexity, ethical conflicts, and decision dilemmas in intensive care unit (ICU) settings. This study aimed to develop a decision aid (DA) for the family surrogate of critically ill patients to support their engagement in shared decision-making process with clinicians.

Methods

Development of DA employed a systematic process with user-centered design (UCD) principle, which included: (i) competitive analysis: searched, screened, and assessed the existing DAs to gather insights for design strategies, developmental techniques, and functionalities; (ii) user needs assessment: interviewed family surrogates in our hospital to explore target user group's decision-making experience and identify their unmet needs; (iii) evidence syntheses: integrate latest clinical evidence and pertinent information to inform the content development of DA.

Results

The competitive analysis included 16 relevant DAs, from which we derived valuable insights using existing resources. User decision needs were explored among a cohort of 15 family surrogates, revealing four thematic issues in decision-making, including stuck into dilemmas, sense of uncertainty, limited capacity, and delayed decision confirmation. A total of 27 articles were included for evidence syntheses. Relevant decision-making knowledge on disease and treatment, as delineated in the literature sourced from decision support system or clinical guidelines, were formatted as the foundational knowledge base. Twenty-one items of evidence were extracted and integrated into the content panels of benefits and risks of RRT, possible outcomes, and reasons to choose. The DA was drafted into a web-based phototype using the elements of UCD. This platform could guide users in their preparation of decision-making through a sequential four-step process: identifying treatment options, weighing the benefits and risks, clarifying personal preferences and values, and formulating a schedule for formal shared decision-making with clinicians.

Conclusions

We developed a rapid prototype of DA tailored for family surrogate decision makers of critically ill patients in need of RRT in ICU setting. Future studies are needed to evaluate its usability, feasibility, and clinical effects of this intervention.

目的 肾脏替代疗法(RRT)越来越多地被确诊为急性肾损伤的重症患者所采用,但最佳的启动时间仍不明确,预后也不确定,导致重症监护病房(ICU)的医疗复杂性、伦理冲突和决策困境。本研究旨在为重症患者的代理家属开发一种决策辅助工具(DA),以支持他们参与与临床医生的共同决策过程。方法 DA 的开发采用了以用户为中心的设计(UCD)原则的系统流程,其中包括(i)竞争分析:搜索、筛选和评估现有的DA,以收集对设计策略、开发技术和功能的见解;(ii)用户需求评估:采访家庭代理,以探索目标用户群的决策经验,并确定他们未满足的需求;(iii)证据综合:整合最新的临床证据和相关信息,为DA的内容开发提供依据。我们对 15 位家庭代理的用户决策需求进行了调查,发现了决策中的四个主题问题,包括陷入两难境地、不确定感、能力有限和决策确认延迟。共有 27 篇文章被纳入证据综述。从决策支持系统或临床指南中获取的相关疾病和治疗决策知识被格式化为基础知识库。提取了 21 项证据,并将其整合到 RRT 的益处和风险、可能的结果以及选择的理由等内容板块中。利用统一设计元素,将数据采集草拟成基于网络的图片模型。该平台可指导用户通过以下四个步骤为决策做准备:确定治疗方案、权衡益处和风险、明确个人偏好和价值观、制定与临床医生正式共同决策的时间表。未来的研究需要评估这一干预措施的可用性、可行性和临床效果。
{"title":"Development of a Decision Aid for Family Surrogate Decision Makers of Critically Ill Patients Requiring Renal Replacement Therapy in ICU: A User-Centered Design for Rapid Prototyping","authors":"","doi":"10.24920/004326","DOIUrl":"10.24920/004326","url":null,"abstract":"<div><h3>Objective</h3><p>Renal replacement therapy (RRT) is increasingly adopted for critically ill patients diagnosed with acute kidney injury, but the optimal time for initiation remains unclear and prognosis is uncertain, leading to medical complexity, ethical conflicts, and decision dilemmas in intensive care unit (ICU) settings. This study aimed to develop a decision aid (DA) for the family surrogate of critically ill patients to support their engagement in shared decision-making process with clinicians.</p></div><div><h3>Methods</h3><p>Development of DA employed a systematic process with user-centered design (UCD) principle, which included: (i) competitive analysis: searched, screened, and assessed the existing DAs to gather insights for design strategies, developmental techniques, and functionalities; (ii) user needs assessment: interviewed family surrogates in our hospital to explore target user group's decision-making experience and identify their unmet needs; (iii) evidence syntheses: integrate latest clinical evidence and pertinent information to inform the content development of DA.</p></div><div><h3>Results</h3><p>The competitive analysis included 16 relevant DAs, from which we derived valuable insights using existing resources. User decision needs were explored among a cohort of 15 family surrogates, revealing four thematic issues in decision-making, including stuck into dilemmas, sense of uncertainty, limited capacity, and delayed decision confirmation. A total of 27 articles were included for evidence syntheses. Relevant decision-making knowledge on disease and treatment, as delineated in the literature sourced from decision support system or clinical guidelines, were formatted as the foundational knowledge base. Twenty-one items of evidence were extracted and integrated into the content panels of benefits and risks of RRT, possible outcomes, and reasons to choose. The DA was drafted into a web-based phototype using the elements of UCD. This platform could guide users in their preparation of decision-making through a sequential four-step process: identifying treatment options, weighing the benefits and risks, clarifying personal preferences and values, and formulating a schedule for formal shared decision-making with clinicians.</p></div><div><h3>Conclusions</h3><p>We developed a rapid prototype of DA tailored for family surrogate decision makers of critically ill patients in need of RRT in ICU setting. Future studies are needed to evaluate its usability, feasibility, and clinical effects of this intervention.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141071591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Chinese Multi-Specialty Delphi Consensus to Optimize RAASi Usage and Hyperkalaemia Management in Patients with Chronic Kidney Disease and Heart Failure 中国多专科德尔菲共识:优化慢性肾病和心衰患者 RAASi 的使用和高钾血症管理
Q2 Medicine Pub Date : 2024-06-01 DOI: 10.24920/004327

Objective

Variations are present in common clinical practices regarding best practice in managing hyperkalaemia (HK), there is therefore a need to establish a multi-specialty approach to optimal rennin-angiotension-aldosterone system inhibitors (RAASi) usage and HK management in patients with chronic kidney disease (CKD) & heart failure (HF). This study aimed to establish a multi-speciality approach to the optimal use of RAASi and the management of HK in patients with CKD and HF.

Methods

A steering expert group of cardiology and nephrology experts across China were convened to discuss challenges to HK management through a nominal group technique. The group then created a list of 41 statements for a consensus questionnaire, which was distributed for a further survey in extended panel group of cardiologists and nephrologists across China. Consensus was assessed using a modified Delphi technique, with agreement defined as “strong” (≥75% and <90%) and “very strong” (≥90%). The steering group, data collection, and analysis were aided by an independent facilitator.

Results

A total of 150 responses from 21 provinces across China were recruited in the survey. Respondents were comprised of an even split (n=75, 50%) between cardiologists and nephrologists. All 41 statements achieved the 75% consensus agreement threshold, of which 27 statements attained very strong consensus (≥90% agreement) and 14 attained strong consensus (agreement between 75% and 90%).

Conclusion

Based on the agreement levels from respondents, the steering group agreed a set of recommendations intended to improve patient outcomes in the use of RAASi therapy and HK management in China.

目的:在处理高钾血症(HK)的最佳实践方面,常见的临床实践存在差异,因此有必要建立一种多专业方法,以优化肾素-血管紧张素-醛固酮系统抑制剂(RAASi)的使用以及慢性肾脏病(CKD)和心力衰竭(HF)患者的HK管理:由来自中国各地的心脏病学和肾脏病学专家组成的专家指导小组召开会议,通过名义小组技术(NGT)讨论香港管理面临的挑战。然后,专家组编制了一份包含 41 项陈述的共识调查问卷,并将其分发给全国各地的心脏病学家和肾脏病学家组成的扩大小组,以进一步调查。采用改良的德尔菲技术对共识进行评估,将一致定义为 "强"(≥75%)和 "结果":调查共收到来自全国 21 个省份的 150 份回复。受访者中心脏病专家和肾病专家各占一半(75 人,50%)。所有 41 项陈述均达到了 75% 的共识一致阈值,其中 27 项陈述达到了非常强烈的共识(≥ 90% 的一致),14 项陈述达到了强烈的共识(75% 至 90% 的一致)。结论根据受访者的同意程度,指导小组达成了一系列建议,旨在改善中国使用 RAASi 治疗和香港管理的患者预后。
{"title":"A Chinese Multi-Specialty Delphi Consensus to Optimize RAASi Usage and Hyperkalaemia Management in Patients with Chronic Kidney Disease and Heart Failure","authors":"","doi":"10.24920/004327","DOIUrl":"10.24920/004327","url":null,"abstract":"<div><h3>Objective</h3><p>Variations are present in common clinical practices regarding best practice in managing hyperkalaemia (HK), there is therefore a need to establish a multi-specialty approach to optimal rennin-angiotension-aldosterone system inhibitors (RAASi) usage and HK management in patients with chronic kidney disease (CKD) &amp; heart failure (HF). This study aimed to establish a multi-speciality approach to the optimal use of RAASi and the management of HK in patients with CKD and HF.</p></div><div><h3>Methods</h3><p>A steering expert group of cardiology and nephrology experts across China were convened to discuss challenges to HK management through a nominal group technique. The group then created a list of 41 statements for a consensus questionnaire, which was distributed for a further survey in extended panel group of cardiologists and nephrologists across China. Consensus was assessed using a modified Delphi technique, with agreement defined as “strong” (≥75% and &lt;90%) and “very strong” (≥90%). The steering group, data collection, and analysis were aided by an independent facilitator.</p></div><div><h3>Results</h3><p>A total of 150 responses from 21 provinces across China were recruited in the survey. Respondents were comprised of an even split (<em>n</em>=75, 50%) between cardiologists and nephrologists. All 41 statements achieved the 75% consensus agreement threshold, of which 27 statements attained very strong consensus (≥90% agreement) and 14 attained strong consensus (agreement between 75% and 90%).</p></div><div><h3>Conclusion</h3><p>Based on the agreement levels from respondents, the steering group agreed a set of recommendations intended to improve patient outcomes in the use of RAASi therapy and HK management in China.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141284967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese Medical Sciences Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1